{
    "label": "Conditions of use",
    "node_type": "fieldset",
    "children": [
        {
            "label": "For Adult Use",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Initiation of Wegovy™ (semaglutide) may be approved for up to for 7 months when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Individual is ≥ 18 years of age",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual has engaged in behavioral modification and dietary restriction for at least 3 months",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual meets one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Current body mass index (BMI) ≥ 30 kg/m^2",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets body mass index (BMI) and comorbidity requirements:",
                                            "all_required": true,
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [
                
                                                {
                                                    "label": "Current body mass index (BMI) ≥ 27 kg/m^2",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "The patient has at least one weight-related comorbid condition:",
                                                    "node_type": "checkbox",
                                                    "node_value": false,
                                                    "children": [
                                                        {
                                                            "label": "Established cardiovascular disease or stroke",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Type 2 diabetes (DM)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Chronic kidney disease (CKD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Congenital heart disease (CHD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Obstructive sleep apnea",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Polycystic ovarian syndrome",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Dyslipidemia",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Non-alcoholic fatty liver disease",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Idiopathic intracranial hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        },
                                                        {
                                                            "label": "Osteoarthritis in weight-bearing joints",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "comorbidity": true
                                                        }
                                                    ]
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "label": "Wegovy will be used alongside behavioral modification and a reduced-calorie diet",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Continuation of Wegovy™ (semaglutide) therapy may be approved when all of the criteria are met (approve duration is based on meeting criteria)",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Individual is ≥ 18 years of age",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual meets one of the following baseline conditions:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Had a BMI ≥ 30 kg/m2",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Had a BMI ≥ 27 kg/m2 and had at least one weight-related comorbidity",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Wegovy will be used alongside behavioral modification and a reduced-calorie diet",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual meets one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Is able to tolerate a Wegovy maintenance dose of 2.4 mg once weekly (Approve for 1 year)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets both of the following:",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "all_required": true,
                                            "children": [
                                                {
                                                    "label": "Has received < 12 consecutive months of Wegovy",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "Is continuing to titrate the Wegovy dose to a target of 2.4 mg once weekly (Approve for up to 5 months)",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "label": "For patients aged 12 to 17 years",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy",
                            "outcome": "Initiation of Wegovy™ (semaglutide) may be approved for up to 7 months when all of the following criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Individual is ≥ 12 years of age and < 18 years of age",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual has engaged in behavioral modification and dietary restriction for at least 3 months",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual currently has a BMI ≥ 95th percentile for age and sex",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Wegovy will be used alongside behavioral modification and a reduced-calorie diet",
                                    "node_type": "checkbox",
                                    "node_value": false
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Continuation of Wegovy™ (semaglutide) therapy may be approved for up to an additional 365 days (1 year) when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Individual is ≥ 12 years of age and < 18 years of age",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "At baseline, the individual had a BMI ≥ 95th percentile for age and sex",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual has had a reduction in BMI of ≥ 1% from baseline",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Wegovy will be used alongside behavioral modification and a reduced-calorie diet",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Individual meets one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Is able to tolerate a Wegovy maintenance dose of 2.4 mg once weekly (Approve for 1 year)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets both of the following:",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "all_required": true,
                                            "children": [
                                                {
                                                    "label": "Has received < 12 consecutive months of Wegovy",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "Is continuing to titrate the Wegovy dose to a target of 2.4 mg once weekly (Approve for up to 5 months)",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "label": "Conditions Not Covered",
            "outcome": "Authorization for Wegovy™ (semaglutide) is not approved",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Glucagon-Like Peptide-1 Agonists (Saxenda® and Wegovy™) are considered experimental, investigational or unproven for ANY other use",
                    "node_type": "checkbox",
                    "node_value": false
                },
                {
                    "label": "Use with other weight loss medications. Use with other medications intended for weight loss is not recommended",
                    "node_type": "checkbox",
                    "node_value": false
                }
            ]
        }
    ]
}